课题基金 / 基金详情

A study on the airway remodeling in an asthma model using bikunin knock out mice.

A study on the airway remodeling in an asthma model using bikunin knock out mice.
使用 Bikunin 基因敲除小鼠进行哮喘模型气道重塑的研究。
批准号:
17590807
负责人:
YAMAGUCHI Etsuro
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

YAMAGUCHI Etsuro的其他基金

相似基金

相关文献

中文摘要
翻译
【目的】透明质酸可能通过影响气道粘液生成和纤毛搏动与哮喘发病有关。为了直接证明这一假设,我们使用bikunin敲除(BXO)小鼠研究了气道反应性,这是血清源性透明质酸南相关蛋白(SHAP)转移反应所必需的。【方法】制备DBA1或BALBC两种BXO小鼠。我们分别在第1天和第15天给小鼠腹腔注射卵清蛋白(OVA)与盐酸铝混合致敏。通过吸入1% OVA溶液进行气道致敏,从第23天至36天持续2周,或从第23天至50天持续4周。分别在第22天或第37天、第26天或第37天用体容积描记仪(Buxco)测量非特异性气道对甲胆碱的反应和ova特异性气道反应。【结果】吸入OVA致敏后3天、10天,野生小鼠和BXO小鼠对OVA的即时气道反应无显著差异。吸入甲胆碱的非特异性气道反应也得到了类似的结果。两株血清ova特异性IgE和IgG水平及支气管肺泡灌洗结果无显著差异。即使在致敏4周的小鼠中,两种菌株的气道反应也没有显著差异;然而,BXO小鼠血清中ova特异性IgG水平显著升高。【讨论】在目前的研究中,我们未能发现气道反应的明显差异。我们也应该通过测量气管内压力来评估气道反应,而不是通过体表容积描记术。我们还应证实HA或SHAP含量的改变是气道病理改变的先决条件。
英文摘要
【Aims】 It is possible that hyarulonan is related to the pathogenesis of asthma by affecting mucus production and ciliary beat in airways. In order to directly prove this hypothesis, we investigated airway responsiveness using bikunin knock out (BXO) mice, which is essential for the transfer reaction of serum-derived hyarulonan associated protein (SHAP).【Methods】 We made BXO mice form DBA1 or BALBC strain. We sensitized mice with intraperitoneal injection of ovalbumin (OVA) mixed with aluminum hydrochloride at days 1 and 15. Airway sensitization was done by inhalation of 1% OVA solution for 2 weeks from day 23 to 36, or for 4 weeks from day 23 to 50. Nonspecific airway responses to methacholine and OVA-specific airway responses were measured by body pletysmograph (Buxco) at day 22 or day 37, and at day 26 or day 37, respectively.【Results】 There was no significant difference in immediate airway responses to OVA between wild and BXO mice three days or ten days after the initiation of sensitization with OVA inhalation. Similar results were obtained for nonspecific airway responses to methacholine inhalation. No significant difference was observed for serum levels of OVA-specific IgE and IgG, and for bronchoalveolar lavage findings between the two strains. No significant difference was found for airway responses even in 4-week sensitization mice between the two strains ; however, serum levels of OVA-specific IgG were significantly increased in BXO mice.【Discussion】 We have failed to find distinct differences in airway responses in the current study. We should evaluate airway responses also by measuring intratracheal pressure not by body pletysmography. We should also verify the existence of altered content of HA or SHAP as a prerequisite of pathological changes in airways.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation on the Roles of Cathepsin S in Sarcoidosis
  • 批准号:
    21591010
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.16万
  • 财政年份:
    2009
  • 负责人:
    YAMAGUCHI Etsuro
  • 依托单位:
Transcriptome Scan in Sarcoidosis
  • 批准号:
    19590921
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2007
  • 负责人:
    YAMAGUCHI Etsuro
  • 依托单位:
Prognosis of the TNF Gene Polymorphism and Sarcoidosis
  • 批准号:
    10670526
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.92万
  • 财政年份:
    1998
  • 负责人:
    YAMAGUCHI Etsuro
  • 依托单位:
Identification of Genes for High IgE responsiveness in Chromosomes 5q31 and 11q13
  • 批准号:
    10307013
  • 项目类别:
    Grant-in-Aid for Scientific Research (A).
  • 资助金额:
    $15.62万
  • 财政年份:
    1998
  • 负责人:
    YAMAGUCHI Etsuro
  • 依托单位:
国内基金
海外基金
CircSLTM及其编码多肽SLTM-99aa通过SAFB介导的mRNA剪接重塑在胃癌发生发展中的分子机制及其临床价值研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    胡柯峰
  • 依托单位:
选择性肾去神经术在心房颤动诱发、维持中的作用及心房电重构的影响
  • 批准号:
    CSTB2023NSCQ-BHX0053
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2023
  • 负责人:
    刘航
  • 依托单位:
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
  • 批准号:
    82371825
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    占贞贞
  • 依托单位:
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
  • 批准号:
    82372202
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    侯旭敏
  • 依托单位: